Skip to main content
TipRanks
Go Ultimate75% OFF

James R O Reagan Insider Profile

4 Followers

James R O Reagan, former VP - R&D and Engineering at Span-America Medical Systems, holds 18.82K shares in Span-America Medical Systems (Ticker: SPAN).

James R O Reagan's Trading History

SPAN
Span-America Medical Systems
Jun 21, 2017―Uninformative Sell598.59K$564.35K
SPAN
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jun 21, 2017Uninformative Sell$598.59K20,641$29.00―
Sep 19, 2016Informative Sell$13.87K760$18.25―
Feb 02, 2016Informative Sell$12.07K619$19.50-9.50%
Mar 03, 2015Informative Sell$18.91K1,022$18.50-6.00%
Feb 05, 2015Informative Buy$23.70K2,582$9.18+7.00%

You May Also Like

James R O Reagan insider profile FAQ

What is the percentage of profitable transactions made by James R O Reagan?
The percentage of profitable transactions made by James R O Reagan is 25%.
What is the average return per transaction made by James R O Reagan?
The average return per transaction made by James R O Reagan is -3.30%.
What stocks does James R O Reagan hold?
James R O Reagan holds: SPAN stocks.
What was James R O Reagan’s latest transaction?
James R O Reagan’s latest transaction was an Uninformative Sell of $598.59K.
What was James R O Reagan's most profitable transaction?
James R O Reagan’s most profitable transaction was an Informative Buy of SPAN stock on February 5, 2015. The return on the trade was 7.00%.
What is James R O Reagan's role in Span-America Medical Systems?
James R O Reagan's role in Span-America Medical Systems is VP - R&D and Engineering.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.